Suppr超能文献

一种与表皮生长因子(EGF)结合的截短受体形式对EGF受体酪氨酸激酶活性的抑制作用:受体间相互作用在激酶调节中的作用。

Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation.

作者信息

Basu A, Raghunath M, Bishayee S, Das M

机构信息

Department of Biochemistry and Biophysics, Children's Hospital of Philadelphia, Pennsylvania.

出版信息

Mol Cell Biol. 1989 Feb;9(2):671-7. doi: 10.1128/mcb.9.2.671-677.1989.

Abstract

The tyrosine kinase activity of the epidermal growth factor (EGF) receptor is regulated by a truncated receptor of 100 kilodaltons (kDa) that contains the EGF-binding site but not the kinase domain. The inhibition of kinase is not due to competition for available EGF or for the kinase substrate-binding site. Chemical cross-linking studies suggest that the 100-kDa receptor may form a heterodimer with the intact EGF receptor. Structurally related receptor kinases, such as the platelet-derived growth factor receptor, the insulin receptor, and the Neu receptor, were not inhibited by the 100-kDa receptor. The results indicate that (i) the inhibition was specific for the EGF receptor, (ii) the kinase domain had little or no role in determining target specificity, and (iii) the regulation of kinase may be due to a specific interaction of the 100-kDa receptor with the ligand-binding domain of the EGF receptor kinase.

摘要

表皮生长因子(EGF)受体的酪氨酸激酶活性受一种100千道尔顿(kDa)的截短型受体调控,该受体含有EGF结合位点,但不包含激酶结构域。激酶的抑制并非由于对可用EGF或激酶底物结合位点的竞争。化学交联研究表明,100-kDa受体可能与完整的EGF受体形成异二聚体。结构相关的受体激酶,如血小板衍生生长因子受体、胰岛素受体和Neu受体,不受100-kDa受体的抑制。结果表明:(i)这种抑制对EGF受体具有特异性;(ii)激酶结构域在确定靶标特异性方面作用很小或没有作用;(iii)激酶的调控可能是由于100-kDa受体与EGF受体激酶的配体结合结构域之间的特异性相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8311/362644/e991c934bff8/molcellb00050-0326-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验